# Anti Infective Agents Impact in COVID-19 Pneumonia

> **NCT04453501** · — · COMPLETED · sponsor: **Centre d'Investigation Clinique et Technologique 805** · enrollment: 132 (actual)

## Conditions studied

- COVID
- Pneumonia, Viral

## Interventions

- **DRUG:** favorable outcome

## Key facts

- **NCT ID:** NCT04453501
- **Lead sponsor:** Centre d'Investigation Clinique et Technologique 805
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-02
- **Primary completion:** 2020-04-25
- **Final completion:** 2020-04-25
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2020-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04453501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04453501, "Anti Infective Agents Impact in COVID-19 Pneumonia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04453501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*